Seeing Is Believing
Currently out of the existing stock ratings of Daniel Arias, 97 are a BUY (71.32%), 39 are a HOLD (28.68%).
Analyst Daniel Arias works at STIFEL with a stock forecast success ratio of 57.3% fulfilled within 133.42 days on average.
Daniel Ariasās has documented 270 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, ļ»æBasic Materials sectors.
Most recent stock forecast was given on TXG, 10X Genomics at 01-May-2024.
Analyst best performing recommendations are on NSTG (NANOSTRING TECHNOLOGIES).
The best stock recommendation documented was for ILMN (ILLUMINA) at 9/22/2020. The price target of $280 was fulfilled within 2 days with a profit of $11.49 (4.28%) receiving and performance score of 21.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
163
$23.55 (16.89%)
135
1 months 1 days ago
7/9 (77.78%)
$21.66 (15.32%)
81
Hold
132
$-7.45 (-5.34%)
120
2 months 8 days ago
7/8 (87.5%)
$-5.01 (-3.66%)
151
Sell
125
$-14.45 (-10.36%)
120
2 months 8 days ago
10/12 (83.33%)
$-12.01 (-8.77%)
137
Sell
120
$-19.45 (-13.95%)
100
3 months 11 days ago
4/6 (66.67%)
$-9.88 (-7.61%)
109
Buy
165
$25.55 (18.32%)
150
4 months 16 days ago
6/9 (66.67%)
$27.05 (19.61%)
268
Which stock is Daniel Arias is most bullish on?
Which stock is Daniel Arias is most reserved on?
What Year was the first public recommendation made by Daniel Arias?